Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain

Thrombosis and Haemostasis

Volumn 79, Issue 1, 1998, Pages 104-109

  Takamiya, Osamu ^a  

^a SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY;

ANTIGEN RECOGNITION; ARTICLE; IMMUNOBLOTTING; PRIORITY JOURNAL;

EID: 0031984017     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614229     Document Type: Article

References (25)

1. Broze GJ, Majerus PW. Purification and properties of human coagulation factor VII. J Biol Chem 1980; 255: 1242-7.
2. Bajaj SP, Rapaport SI, Brown SF. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem 1981; 256: 253-9.
3. Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007-20.
4. Masys DR, Bajaj SP and Rapaport SI. Activation of human factor VII by activated factors IX and X. Blood 1982; 60: 1143-50.
5. Kisiel W, Fujikawa K and Davie EW. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). Biochemistry 1977; 16: 4189-94.
6. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30: 10819-24.
7. Wildgoose P, Kisiel W. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. Blood 1983; 73: 1888-95.
8. Hougie C. Hemophilia and related conditions - congenital deficiencies of prothrombin (factor II), factor V, and factors VII to XII. In: Disorders of hemostasis - congential disorders of blood coagulation factors: Hematology. Williams WJ, Ernest B, Allan JE, Marshall AL (eds). Third edication. McGraw-Hill, New York, 1994; pp 1393-4.
9. Takamiya O, Abe S, Yoshioka A, Nakajima K, McVey J.H, Tuddenham E.G.D. Factor VII Shinjo: A dysfunctional factor VII variant homozygous for the substitution Gln for Arg at position 79. Haemosta 1995; 25: 89-97.
10. Takamiya O, Kinoshita S, Yoshioka K. Electroimmunoassay of factor VII antigen. Thromb Res 1986; 42: 847-53.
11. Galfre G, Milstein C. Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol 1981; 73: 3-46.
12. Kasper CK, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 869-72.
13. Kimoto H. Measurement of affinity for monoclonal antibody - solid assay -. Saibokogaku 1985; 100-4 (in Japanese).
14. Takamiya O, Nakamura S, Yoshioka A. A solid-phase assay for the binding ability of factor VII to human tissue factor. Special reference to 8 patients with congential factor VII abnormalities. Jap J Thromb Hemostas 1994; 5: 254-61 (in Japanese).
15. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
16. Turkington PT, Cathepsin G, a regulator of human vitamin K dependent clotting factors and inhibitors. Thromb Res 1992; 67: 147-55.
17. Kazama Y, Pastuszyn A, Wildgoose P, Hamamoto T, Kisiel W. Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa*. J Biol Chem 1993; 268: 16231-40.
18. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor-VII. Proc Natl Acad Sci USA 1986; 83: 2412-16.
19. Coppola R, Tombesi S, Valentini F, Alborali S, Albertini A, Mannucci PM. Characterization of a Ca (II)-independent monoclonal antibody that lacks reactivity with gla domainless human factor VII. Thromb Res 1992; 68: 269-81.
20. Cheung W-F, Stafford DW. Localization of an epitope of a calcium-dependent monoclonal antibody to the N-terminal region of the gla domain of human factor VII. Thromb Res 1995; 79: 199-206.
21. Higashi S, Kawabata S, Nishimura H, Funasaki H, Ohyama S, Miyamoto S, Funatsu A, Iwanaga S. Monoclonal antibody (VII-M13) to bovine factor VII: A specific epitope in the γ-carboxyglutamic acid domain. J Biochem 1990; 108: 654-62.
22. Takamiya O, Kemball-Cook G, Martin DMA, Cooper DN, von Felten A, Meile E, Hann I, Prangnell DR, Lumley H, Tuddenham EGD, McVey JH: Detection of missense mutations by single-strand conformational polymorphism (SSCP) analysis of coagulation variants of coagulation factor VII. Human Mol Genet 1988; 2: 1355-9.
23. Church WR, Messier T, Howard PR, Amiral J, Meyer D, Mann KD. A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding. J Biol Chem 1988; 263: 6259-67.
24. 2+ ion binding sites in factor Vila and in des(1-38) factor VIIa. FEBS Lett 1992; 306: 265-8.
25. Wildgoose, P, Foster, D, Schiodt, J, Wiberg, FC, Birktoft, J. Petersen, LC. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction. Biochemistry 1993; 32: 114-9.